Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombusdoi:10.1016/j.aohep.2021.100552PATIENT portalsPORTAL veinHEPATOCELLULAR carcinomaCHEMOEMBOLIZATIONTHROMBOSISIntroduction and objectives: Optimal treatment of hepatocellular carcinoma (HCC...
1.1. Overview, risk factors for cancer patients and COVID-19 SARS-CoV-2 is a highly pathogenic corona virus also called COVID-19. It is a single-stranded, positive-sense RNA virus, which means the viral RNA can be directly translated in viral proteins in infected cells. Infection with SAR...
Are you a Patient? Shipping options for your Hep C medicines We deliver your medication, normally the next day, throughout to USA and to most international destinations via various shipping options. We also have the ability to have your prescription dispensed from one of our many pharmacy locati...
Next Generation Electrotherapy for viral, bacterial, H Pylori, MRSA, Hep B, Hep C, pneumonia, bronchitis, ENT, UTI, HPV, herpes, antibiotic resistant superbugs, acute and chronic infections; wound healing electrical stimulation machines, electrotherapy d
Until recently, only two medicines were used to treat hep C interferon and ribavirin. But these drugs: Often required weekly injections for almost a year! Only cured half of those treated And caused life-threatening side effects Now, new treatments called Direct Antiviral Agents -- or DAAs --...
Bladder instillations can be used to calm and soothe the bladder, particularly during flares. During a bladder instillation (aka intravesical instillation or treatment), the bladder is filled with medication via a catheter. The solution is held for varying periods of time, from a few seconds to...
Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer’s disease.
Topical agents do not have a large market share in the treatment of chronic pain. The total market for over-the-counter analgesics alone is estimated at $2.38 billion [1]. In 2007, the market for topical analgesics (TAs) was only $40 million [2]. These data suggest that these treatment...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Forest plots for all-cause mortality (a) and for severe hypoglycaemia (b) [13] Full size image Based on these results, researchers concluded that intensive glycaemic control did reduce all-cause mortality in patients with T2DM and the data available were insufficient to prove or refute a relativ...